The Fort Worth Press - Who should get paid for nature's sequenced genes?

USD -
AED 3.673042
AFN 65.503991
ALL 82.770403
AMD 381.503986
ANG 1.790055
AOA 917.000367
ARS 1431.358504
AUD 1.505118
AWG 1.8
AZN 1.70397
BAM 1.678705
BBD 2.013364
BDT 122.282772
BGN 1.67999
BHD 0.376283
BIF 2967
BMD 1
BND 1.294944
BOB 6.907739
BRL 5.439604
BSD 0.999601
BTN 89.876145
BWP 13.280747
BYN 2.873917
BYR 19600
BZD 2.010437
CAD 1.38275
CDF 2232.000362
CHF 0.804198
CLF 0.0235
CLP 921.880396
CNY 7.070104
CNH 7.069041
COP 3833.1
CRC 488.298936
CUC 1
CUP 26.5
CVE 95.103894
CZK 20.783504
DJF 177.720393
DKK 6.414904
DOP 64.250393
DZD 129.723093
EGP 47.482076
ERN 15
ETB 155.150392
EUR 0.858704
FJD 2.26045
FKP 0.748861
GBP 0.749625
GEL 2.69504
GGP 0.748861
GHS 11.45039
GIP 0.748861
GMD 73.000355
GNF 8687.503848
GTQ 7.657084
GYD 209.137648
HKD 7.78495
HNL 26.280388
HRK 6.470704
HTG 130.859652
HUF 328.020388
IDR 16689.55
ILS 3.23571
IMP 0.748861
INR 89.958504
IQD 1310
IRR 42112.503816
ISK 127.980386
JEP 0.748861
JMD 159.999657
JOD 0.70904
JPY 155.370385
KES 129.303801
KGS 87.450384
KHR 4005.00035
KMF 422.00035
KPW 899.993191
KRW 1473.803789
KWD 0.30697
KYD 0.833083
KZT 505.531856
LAK 21690.000349
LBP 89550.000349
LKR 308.334728
LRD 176.903772
LSL 16.950381
LTL 2.95274
LVL 0.60489
LYD 5.450381
MAD 9.236504
MDL 17.00842
MGA 4487.000347
MKD 52.906919
MMK 2099.939583
MNT 3546.502114
MOP 8.016033
MRU 39.860379
MUR 46.103741
MVR 15.403739
MWK 1737.000345
MXN 18.174204
MYR 4.111039
MZN 63.910377
NAD 16.950377
NGN 1450.080377
NIO 36.775039
NOK 10.105104
NPR 143.802277
NZD 1.730703
OMR 0.383822
PAB 0.999682
PEN 3.517504
PGK 4.187504
PHP 58.965038
PKR 280.375038
PLN 3.63215
PYG 6875.152888
QAR 3.64105
RON 4.372604
RSD 100.993038
RUB 76.367149
RWF 1451
SAR 3.753173
SBD 8.230592
SCR 13.523679
SDG 601.503676
SEK 9.40005
SGD 1.295404
SHP 0.750259
SLE 23.703667
SLL 20969.498139
SOS 571.503662
SRD 38.629038
STD 20697.981008
STN 21.4
SVC 8.745763
SYP 11058.244165
SZL 16.950369
THB 31.875038
TJS 9.171638
TMT 3.51
TND 2.95125
TOP 2.40776
TRY 42.526038
TTD 6.776446
TWD 31.289038
TZS 2435.000335
UAH 41.959408
UGX 3536.283383
UYU 39.096531
UZS 12005.000334
VES 254.551935
VND 26360
VUV 122.070109
WST 2.790151
XAF 563.019389
XAG 0.017168
XAU 0.000238
XCD 2.70255
XCG 1.801608
XDR 0.70002
XOF 562.503593
XPF 102.875037
YER 238.550363
ZAR 16.926304
ZMK 9001.203584
ZMW 23.111058
ZWL 321.999592
  • RBGPF

    0.0000

    78.35

    0%

  • AZN

    0.1500

    90.18

    +0.17%

  • RELX

    -0.2200

    40.32

    -0.55%

  • RYCEF

    -0.0500

    14.62

    -0.34%

  • CMSC

    -0.0500

    23.43

    -0.21%

  • SCS

    -0.0900

    16.14

    -0.56%

  • BTI

    -1.0300

    57.01

    -1.81%

  • VOD

    -0.1630

    12.47

    -1.31%

  • NGG

    -0.5000

    75.41

    -0.66%

  • GSK

    -0.1600

    48.41

    -0.33%

  • BCC

    -1.2100

    73.05

    -1.66%

  • CMSD

    -0.0700

    23.25

    -0.3%

  • RIO

    -0.6700

    73.06

    -0.92%

  • JRI

    0.0400

    13.79

    +0.29%

  • BCE

    0.3300

    23.55

    +1.4%

  • BP

    -1.4000

    35.83

    -3.91%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

T.Harrison--TFWP